TAVR Planning Simulation
Pre-procedural planning for Transcatheter Aortic Valve Replacement
Key Facts
About DASI Simulations
DASI Simulations is a private, commercial-stage company founded in 2020 and headquartered in Boston, MA. It has developed an FDA-cleared AI platform that generates patient-specific cardiac simulations to predict complications like coronary obstruction and leaflet thrombosis prior to TAVR procedures. The company has established significant commercial partnerships with industry leaders like Medtronic and the Cleveland Clinic, indicating early market validation and a services-based business model focused on selling simulations to hospitals and health systems. DASI operates at the intersection of AI, computational modeling, and interventional cardiology, targeting a large and growing structural heart disease market.
View full company profile